{"id":30512,"date":"2022-06-20T23:34:00","date_gmt":"2022-06-20T15:34:00","guid":{"rendered":"https:\/\/flcube.com\/?p=30512"},"modified":"2025-03-25T23:39:55","modified_gmt":"2025-03-25T15:39:55","slug":"chinas-seventh-national-volume-based-procurement-round-kicks-off-with-revised-rules","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=30512","title":{"rendered":"China&#8217;s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules"},"content":{"rendered":"\n<p>China&#8217;s health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related delay. The Shanghai Sunshine Medical Procurement All-in-One (SMPA) platform has issued a notification outlining the bidding and procurement rules for 61 drug varieties across 147 specifications. The round will involve nearly 300 manufacturers, with competitive bidding scheduled for July 12.<\/p>\n\n\n\n<p><strong>Bidding Rules<\/strong><br>The maximum number of manufacturers that can be shortlisted remains at 10, as per last year. However, the rules for winning bids and dividing regional supply contracts have been revised.<\/p>\n\n\n\n<p><strong>Winning Bid Conditions<\/strong><br>To secure a tender spot, two conditions must be met simultaneously:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>One of the following must be satisfied:\n<ul class=\"wp-block-list\">\n<li>The &#8220;unit comparable price&#8221; is \u22641.8 times the lowest &#8220;unit comparable price&#8221; of the same variety.<\/li>\n\n\n\n<li>The &#8220;unit comparable price&#8221; is \u2264 RMB 0.10.<\/li>\n\n\n\n<li>The &#8220;unit filing price&#8221; decrease rate is \u226550.00% (capped at the highest valid filing price).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>If Condition 1 is achieved:\n<ul class=\"wp-block-list\">\n<li>A winning bid cannot be the highest price among eligible bids.<\/li>\n\n\n\n<li>A scoring system will be applied, and the top 6 excluded will be selected.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p><strong>Supply Region Allocation<\/strong><br>Spare supply regions have been added to the supply regions. The process is as follows:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Winning manufacturers first confirm their primary supply regions. The highest-ranked manufacturer (lowest unit bid price) has priority in selecting a supply region.<\/li>\n\n\n\n<li>After the priority selection, all winning manufacturers, starting from the highest-ranked, confirm the remaining regions one by one, with each manufacturer selecting one region per round until all regions are chosen.<\/li>\n\n\n\n<li>After primary supply regions are confirmed, winning manufacturers select spare regions, which must differ from their primary supply regions. If there is only one winning manufacturer, spare supply regions are not required.<\/li>\n\n\n\n<li>Winning manufacturers become spare manufacturers in the spare regions, supplying products online at winning prices. This contrasts with earlier VBP rounds where winning manufacturers could supply products in non-supply regions at higher prices.<\/li>\n<\/ol>\n\n\n\n<p><strong>Primary Supply Manufacturer Replacement<\/strong><br>If the primary supplying manufacturer can meet the market demands of its chosen region, the spare manufacturer can obtain primary supplying manufacturer status according to relevant procedures, as determined by the provincial healthcare security administrations.<\/p>\n\n\n\n<p><strong>Supply Region Confirmation<\/strong><br>Winning manufacturers must confirm their supply regions based on their manufacturing capacities and are required to make a selection when it is their turn. Confirmation must be made under the condition that the regional confirmation rules are met, and no waiver is allowed. Failure to do so will be deemed as Abandoning the qualification to be selected.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[1531,82],"class_list":["post-30512","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-sunshine-medical-procurement","tag-vbp-voluem-based-procurement"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China&#039;s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related delay. The Shanghai Sunshine Medical Procurement All-in-One (SMPA) platform has issued a notification outlining the bidding and procurement rules for 61 drug varieties across 147 specifications. The round will involve nearly 300 manufacturers, with competitive bidding scheduled for July 12.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=30512\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China&#039;s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=30512\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-20T15:34:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-25T15:39:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30512#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30512\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China&#8217;s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules\",\"datePublished\":\"2022-06-20T15:34:00+00:00\",\"dateModified\":\"2025-03-25T15:39:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30512\"},\"wordCount\":418,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Sunshine Medical Procurement\",\"VBP (voluem-based procurement)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30512#respond\"]}],\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30512\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=30512\",\"name\":\"China's Seventh National Volume-based Procurement Round Kicks Off with Revised Rules - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2022-06-20T15:34:00+00:00\",\"dateModified\":\"2025-03-25T15:39:55+00:00\",\"description\":\"China's health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related delay. The Shanghai Sunshine Medical Procurement All-in-One (SMPA) platform has issued a notification outlining the bidding and procurement rules for 61 drug varieties across 147 specifications. The round will involve nearly 300 manufacturers, with competitive bidding scheduled for July 12.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30512#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30512\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30512#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China&#8217;s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China's Seventh National Volume-based Procurement Round Kicks Off with Revised Rules - Insight, China&#039;s Pharmaceutical Industry","description":"China's health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related delay. The Shanghai Sunshine Medical Procurement All-in-One (SMPA) platform has issued a notification outlining the bidding and procurement rules for 61 drug varieties across 147 specifications. The round will involve nearly 300 manufacturers, with competitive bidding scheduled for July 12.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=30512","og_locale":"en_US","og_type":"article","og_title":"China's Seventh National Volume-based Procurement Round Kicks Off with Revised Rules","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=30512","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2022-06-20T15:34:00+00:00","article_modified_time":"2025-03-25T15:39:55+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=30512#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=30512"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China&#8217;s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules","datePublished":"2022-06-20T15:34:00+00:00","dateModified":"2025-03-25T15:39:55+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=30512"},"wordCount":418,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Sunshine Medical Procurement","VBP (voluem-based procurement)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=30512#respond"]}],"copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=30512","url":"https:\/\/flcube.com\/?p=30512","name":"China's Seventh National Volume-based Procurement Round Kicks Off with Revised Rules - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2022-06-20T15:34:00+00:00","dateModified":"2025-03-25T15:39:55+00:00","description":"China's health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related delay. The Shanghai Sunshine Medical Procurement All-in-One (SMPA) platform has issued a notification outlining the bidding and procurement rules for 61 drug varieties across 147 specifications. The round will involve nearly 300 manufacturers, with competitive bidding scheduled for July 12.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=30512#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=30512"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=30512#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China&#8217;s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30512"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30512\/revisions"}],"predecessor-version":[{"id":30513,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30512\/revisions\/30513"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}